EGFR and breast carcinoma: For example, 111In-labelled block copolymer micelles (BCMs) modified with EGF to target EGFR-positive breast cancer cells were assembled by incorporating a DTPA-polyethylene glycol (PEG)-b-polycaprolactone (PCL) block polymer into these micelles (Fonge et al. 2009).